Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Revance Therapeutics Company Profile (NASDAQ:RVNC)

Earnings History for Revance Therapeutics (NASDAQ:RVNC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare
11/12/2014Q314($0.69)($0.60)ViewN/AViewTweet This Announcement  Share This Announcement on StockTwits
8/12/2014($0.68)($0.69)ViewN/AViewTweet This Announcement  Share This Announcement on StockTwits
5/13/2014Q1 14($0.87)($1.93)ViewN/AViewTweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)